Please assess the completion status of the following clinical trial:

Trial Title: Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: None
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of perennial allergic rhinitis (PAR).~* Must comply with study procedures and be literate.~Exclusion Criteria:~* Significant concomitant medical conditions.~* Use of corticosteroids.~* Use of allergy and other identified medications during the study.~* Current tobacco use or tobacco use within the past year.~* Exposure to an investigational study drug within the past 12 months.~* Clinically significant abnormal electrocardiograms (ECG) or laboratory abnormality.

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Fluticasone furoate (Type: EXPERIMENTAL): Participants were instructed to administer two sprays into each nostril once daily every morning of fluticasone furoate 110 μg
- Placebo (Type: PLACEBO_COMPARATOR): Participants were instructed to administer two sprays into each nostril once daily every morning of placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).